84040
Assay of phenylketones, quantitative
The CPT code 84040 is utilized to report the quantitative laboratory assay of phenylketones in a clinical specimen, typically blood or urine. This test is essential for the ongoing management and diagnostic confirmation of Phenylketonuria (PKU), a rare autosomal recessive metabolic disorder characterized by a deficiency in the enzyme phenylalanine hydroxylase (PAH). Without functional PAH, phenylalanine accumulates in the body and converts into phenylketones, which are then excreted in the urine. While qualitative tests (such as the ferric chloride test) can indicate the mere presence of phenylketones, a quantitative assay provides a precise measurement of their concentration. This exact measurement allows for the rigorous monitoring of dietary therapy and therapeutic interventions in PKU patients. The procedure involves sophisticated analytical methodologies such as High-Performance Liquid Chromatography (HPLC), Tandem Mass Spectrometry (MS/MS), or precise enzymatic assays to definitively quantify the phenylketone levels in the provided specimen. The exhaustive description of this code includes the entire process from specimen processing, calibration, running the analytical test, interpreting the results against a standard curve, to the final quantitative analysis and formal laboratory reporting.
Clinical Indications
- Confirmation of a positive newborn screen for Phenylketonuria (PKU) or other hyperphenylalaninemia variants.
- Routine biochemical monitoring of patients with a known diagnosis of PKU to assess strict compliance with a phenylalanine-restricted diet.
- Investigation of pediatric patients presenting with unexplained developmental delay, intellectual disability, microcephaly, or neurological symptoms suggestive of an undiagnosed metabolic disorder.
- Evaluation and ongoing monitoring of maternal PKU to prevent teratogenic effects on the developing fetus during pregnancy.
Procedure Steps
- Specimen Collection: Appropriate collection of a blood or urine sample from the patient following strict clinical and laboratory protocols.
- Specimen Preparation: Centrifugation of blood to obtain plasma/serum, or proper chemical stabilization of the urine sample to prevent degradation of phenylketones.
- Calibration: Running standard calibration curves using known concentrations of phenylketones to ensure assay accuracy and linearity.
- Analytical Run: Introduction of the processed specimen into the analytical instrument (e.g., HPLC, MS/MS, or automated chemistry analyzer).
- Data Acquisition: Capturing the quantitative signal generated by the chemical interaction or molecular separation of the specific analytes.
- Result Interpretation: Comparison of the specimen's signal against the calibration curve to calculate the exact concentration of phenylketones.
- Quality Control: Verification of results using internal and external quality control samples to validate the integrity of the assay run.
- Reporting: Generation of a formal laboratory report detailing the exact quantitative level of phenylketones, ready for clinical review by the ordering physician.
Coding Guidelines
- Do not report CPT 84040 in conjunction with qualitative phenylketone assays (e.g., CPT 84035) for the same specimen on the same date of service unless medically necessary and properly modified.
- For the specific quantitative measurement of phenylalanine in blood, utilize the appropriate specific CPT code (e.g., 84030) rather than 84040.
- Modifier 91 may be appended if the quantitative assay needs to be repeated on the same day for a distinct clinical reason (e.g., assessing rapid metabolic changes after a specific dietary intervention).
- Code 84040 is distinctively specific to the quantitative determination of the metabolite phenylketones, not the parent amino acid phenylalanine.